Table 3.
Sample | Microorganisms | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | |
EO1 | + | + | + | + | + | + | + | + | + | + | + | + | + | + | 0.2 |
EO2 | + | + | + | + | + | + | 0.5 | + | + | ≤0.1 | + | + | + | + | 0.2 |
EOH1 | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
EOH2 | + | + | + | + | + | + | + | + | + | 0.5 | + | + | + | + | + |
+ means the pathogens growth. 1. Klebsiella pneumoniae, 2. Salmonella enterica 24 SPn06, 3. Pseudomonas aeruginosa 17-331, 4. Acinetobacter baumanni 17-380, 5. Proteus mirabilis, 6. 6MRSA M87fox, 7. Enterococcus faecalis 86, 8. Enterococcus faecium 103, 9. Bacillus cereus 18 01, 10. Streptococcus mutans (referent), 11. Enterobacter cloacae, 12. Citrobacter freundii, 13. Staphylococcus epidermidis, 14. Staphylococcus haemolyticus, 15. Pasteurella multocida. Where the growth of bacteria were inhibited, minimal inhibitory concentrations were provided in %.